The research team at Lyon has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation develop tumours, because this gene can no longer induce the death of the cancer cells. This discovery could lead to the development of a new targeted cancer treatment that aims to reactivate the dying of cancer cells...

Patients with breast cancer report greater satisfaction with care when their cancer doctor co-manages their care with other specialists. However, some specialists are more likely than others to share decision-making with other physicians, finds a new study in Health Services Research. "Breast cancer is typically a condition that is managed by multiple specialists...

A breast cancer survivor's breast implant was swallowed up by her own body during a Pilates session, resulting in surgical intervention to retrieve it and place it back into the breast, according to an article by doctors at Johns Hopkins' University and published in NEJM (New England Journal of Medicine). The 59-year-old female had undergone a double mastectomy, followed by breast implants...

An investigation published December 16th in the Journal of the National Cancer Institute reveals that over the last several years in the U.S., accelerated partial breast irradiation using brachytherapy (APBIb) for treating breast cancer has increased rapidly as an alternative treatment to conventional whole-breast irradiation (WBI)...

Some pink Bibles, which were for sale in retail outlets since October 2011, have been recalled because it was discovered that part of their sales money went towards breast cancer screenings at Planned Parenthood, a US family planning organization which also provides abortions. The Southern Baptist Convention's publishing arm says it is recalling the Bibles...

A Queensland University of Technology (QUT) PhD student has developed a potential breakthrough test for predicting the likelihood of the spread or return of breast cancer...

Researchers at Mayo Clinic in Arizona and the University of Georgia (UGA) have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments...

Researchers at the Johns Hopkins Kimmel Cancer Center have demonstrated during their work with breast cells that breast cells become vulnerable to cancer if a single copy of the breast cancer gene BRCA1 is inactivated. It causes genetic instability in the cells through reducing their ability to repair DNA damage...

A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only...

Researchers from the University of Georgia and the Mayo Clinic in Arizona have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments...

Looking for ways to halt the uncontrolled growth of cancer cells, scientists at Johns Hopkins have found that a new class of drugs, called PARP inhibitors, may block the ability of pre-leukemic cells to repair broken bits of their own DNA, causing these cells to self-destruct...

Breast cancer patients frequently undergo imaging like mammograms or ultrasounds between their first breast cancer-related doctor visit and surgery to remove the tumor. Evaluations of these scans help physicians understand a person's disease and determine the best course of action...

Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study by researchers at the North Shore-LIJ Health System's Monter Cancer Center in Lake Success, NY. The findings were reported at the San Antonio Breast Cancer Symposium...

Nab-paclitaxel (Abraxane for Injectable Suspension), at a dose of 150 mg/m2 weekly, improves overall survival (OS) to a much greater degree than conventional taxane monotherapy in women with previously untreated metastatic breast cancer (MBC), according to results of a phase II study released at the 34th Annual San Antonio Breast Cancer symposium (SABCS)...

'Introducing breast cancer screening in the UK may have caused more harm than good', says a new study published on bmj.com that supports the claim...

Recent findings presented by researchers at Genesis Prevention Center at University Hospital in South Manchester, England, at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, have demonstrated that an intermittent, low-carbohydrate diet is preferable to a standard and daily calorie-restricted diet to reduce weight and lower blood levels of insulin...

Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring? The first study to actually ask the women themselves -- as well as the largest, most scientifically rigorous study to examine the question -- reports 36 percent of women quit early because of the medications' side effects, wh...

The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer Center. However, the research shows that these stray tumor cells may signal that the disease has spread to other parts of the body, even before imaging reveals any metastases...

36% of post-menopausal breast cancer patients who take aromatase inhibitors do not complete their treatment, because the drug's side effects are so unpleasant, researchers from the Northwestern University Feinberg School of Medicine reported at the San Antonio Breast Cancer Symposium...

Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients to appropriate therapies, according to preliminary data presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011...